Please assess the completion status of the following clinical trial:

Trial Title: Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes for at least 5 years and receiving insulin as the only T1D therapy~* HbA1c ≥6.0 and ≤9.0 %~* BMI ≥18 to ≤27 kg/m\^2~* Normal thyroid function~Exclusion Criteria:~* Impaired hypoglycemia awareness~* Severe hypoglycemia or diabetic ketoacidosis (DKA) within 3 months~* Abnormal blood pressure or ECG, clinically significant cardiovascular, cerebrovascular or peripheral vascular disease~* History of pheochromocytoma, insulinoma, glucagonoma, acromegaly, Cushing's disease, glycogen storage disease or adrenal insufficiency; ongoing or previous treatment with octreotide, lanreotide or pasireotide~* Current use of systemic corticosteroids or beta-blockers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Treatment order: placebo, low dose, high dose (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps
- Treatment order: placebo, high dose, low dose (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps
- Treatment order: low dose, placebo, high dose (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps
- Treatment order: low dose, high dose, placebo (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps
- Treatment order: high dose, placebo, low dose (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps
- Treatment order: high dose, low dose, placebo (Type: EXPERIMENTAL): Subjects will receive a single administration of each treatment in this order during three consecutive clamps

Based on this trial design, predict the completion outcome and termination type (if applicable).